Redefine what’s possible.
Contact our team today to start transforming your lab.
Transferring study data between software systems is time-consuming. Currently, the experimental workflow requires the user to export and import CSV files between E-WorkBook and SCIEX Analyst™, an inefficient process. For users in a regulated GxP environment, preclinical pharma, for example, the use of CSV files also has implications for regulatory compliance. In market surveys, customers also report needing to use multiple tools, including excel and third-party application to process and interpret data.
In response to the call for a more seamless exchange of information, IDBS and SCIEX are collaborating to integrate SCIEX Analyst™ into E-WorkBook.
With a more automated approach, researchers believed that they could save >11 hours per week, leveraging the integration in combination with the power of the E-WorkBook platform.
The key advantage of the integration component is the ability to seamlessly upload injection sequences and retrieve raw and processed results at the push of a button, providing a tamper-proof method of data exchange and a full audit trail of actions. This innovation enables customers to increase throughput and proactively conform to regulatory compliance.
In addition, the integration helps study design by enabling users to design and upload injection sequence lists to Analyst ™. Not only does this ensure assay standardization, but also cuts cycle times.
Users can also track batches of samples for assays and raise work requests. Assay results can be mapped to a data model, facilitating easy access to historic data for effortless trend analysis and reporting.
IDBS draws on 30 years’ experience supporting preclinical advances and addressing the collaborative, internalized preclinical landscape with its SaaS offerings.
SCIEX delivers solutions for the precision detection and quantification of molecules, empowering their customers to advance life-changing research and outcomes.
As part of the same Danaher family of operating companies, IDBS and SCIEX will continue to strengthen their partnership as part of an on-going initiative to deliver the next-generational preclinical working environment.
Users will be able to improve regulatory compliance by not having to export Analyst™ data as CSV files. Instead, processed results from Analyst™ can be extracted directly from the system.
Uploading injection sequence lists to Analyst™ improves assay standardization, ensures easy data traceability, and reduces cycle times.
Automating batch extraction and processing of Analyst™ data means faster access to historical data for reporting and assay trend analysis.